Leveraging Interleukin-1 Blockade as a Therapeutic Strategy for Cardiac Sarcoidosis: Rationale and Design for the RandomizEd PhAse II TrIal of Rilonacept in Subjects With Cardiac Sarcoidosis (REPAIR-CS).
| Publicado en: | Journal of Cardiac Failure Vol. 32; no. 5; pp. 877 - 888 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
W B Saunders
May2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Descripción no disponible. |